Drug-Induced Hypertension Caused by Multikinase Inhibitors (Sorafenib, Sunitinib, Lenvatinib and Axitinib) in Renal Cell Carcinoma Treatment

This paper reviews current treatments for renal cell carcinoma/cancer (RCC) with the multikinase inhibitors (MKIs) sorafenib, sunitinib, lenvatinib and axitinib. Furthermore, it compares these drugs regarding progression-free survival, overall survival and adverse effects (AE), with a focus on hyper...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Int J Mol Sci
Autors principals: Bæk Møller, Nanna, Budolfsen, Cecilie, Grimm, Daniela, Krüger, Marcus, Infanger, Manfred, Wehland, Markus, E. Magnusson, Nils
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2019
Matèries:
Review
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6801695/
https://ncbi.nlm.nih.gov/pubmed/31547602
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms20194712
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars